Subgroups and sensitivity analyses Prespecified subgroup analyses in the expanded populations for age showed no meaningful treatment effect heterogeneity (Fig
From a clinical perspective, it is important to address such claims with patients who may be seeking alternative approaches to metabolic health
This has a broader population health benefit as greater access to these medicines will reduce the crippling strain obesity-related conditions have on NHS resources. In the UK, generic competition typically reduces prices paid by the NHS by as much as 80% to 90% after loss of exclusivity, according to the BGMA
The efficacy of WEGOVY 25 mg oral once daily tablet for weight reduction and long-term maintenance of body weight in conjunction with a reduced-calorie diet and increased physical activity was evaluated in a 64-week randomized, double-blind, placebo-controlled trial [Study 7 (NCT#05564117)]
Some other less common but more severe side effects of semaglutide include: Low blood sugar (hypoglycemia) Kidney problems Allergic reaction Thyroid cancer Gallbladder problems Pancreatitis If you experience any of these symptoms while taking semaglutide, seek immediate medical attention